[1]
Dr Syed Sujat et al. 2025. COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A PROSPECTIVE OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 1595–1598. DOI:https://doi.org/10.53555/any65e03.